IMPORTANCE Long-term cumulative systolic blood pressure (SBP) is significantly associated with increased rates of atherosclerotic cardiovascular disease (ASCVD) development independent of single SBP levels. However, published ASCVD risk prediction algorithms only include currently measured SBP.
L
ongitudinal systolic blood pressure (SBP) levels are significantly associated with increased incidence of atherosclerotic cardiovascular disease (ASCVD) independent of baseline or proximate SBP levels, suggesting that cumulative SBP may have additional predictive value over single SBP measures. [1] [2] [3] [4] [5] The 2013 American College of Cardiology/American Heart Association pooled cohort 10-year ASCVD risk equations include SBP measured at a single point in time for quantitative risk assessment, ignoring previous blood pressure history that may be informative to ASCVD risk. 6 However, the developers of these equations specifically called for evaluation of whether long-term risk factor levels impact the model performance. 6 In this study, we tested whether using long-term (5-and 10-year) cumulative SBP measures in the 2013 pooled cohort equations could improve the model performance compared with single SBP measurements.
Methods

Study Population
This study used data from the Lifetime Risk Pooling Project cohorts that had adequate blood pressure follow-up during middle age as well as adjudicated ASCVD events: Coronary Artery Risk Development in Young Adults Study, Atherosclerosis Risk in Communities Study, and Framingham Heart Study (both the original and offspring cohorts). 7 We included participants aged 45 to 65 years who were free of ASCVD with at least 20 years of observation time, including up to 10 years prior to risk estimation at the index age and for 10 years or longer of event follow-up after the index age. Included cohorts were approved by institutional review boards at their coordinating institutions, and all participants provided informed consent at each examination.
Blood Pressure Measurement
Blood pressure was reported as the mean of 2 or 3 seated measurements taken by trained personnel using standardized methods. Cumulative SBP was calculated by taking the means of SBP levels from each pair of consecutive examinations, multiplying each mean value by the years between the consecutive visits, and summing all available multiplied means (prior to the index age) to yield a 5-year or 10-year cumulative SBP exposure, expressed as mm Hg-years (similar to pack-years of cigarette exposure).
ASCVD Risk and Event Ascertainment
Using the 2013 American College of Cardiology/American Heart Association pooled cohort equations, 6 three 10-year CVD risks were calculated for each participant, first using current SBP at the index age and then using 5-and 10-year cumulative SBP prior to the index age to represent SBP. These models also included age, sex, race/ethnicity, total cholesterol, high-density lipoprotein cholesterol, antihypertensive medication use, current smoking status, and diabetes. Event ascertainment occurred after the risk estimation and included incident ASCVD, defined as coronary heart disease death, nonfatal myocardial infarction, and fatal or nonfatal stroke. These data were available up to the most recent time of event adjudication by the included cohorts (December 2014 to December 2016).
Statistical Analysis
First, 10-year ASCVD risk equations were fitted using the approach of the 2013 American College of Cardiology/ American Heart Association pooled cohort equations but with local β coefficient estimates corresponding the data of the included cohorts. Three sets of equations were fitted using each of the blood pressure measures of interest (current SBP, 5-year cumulative SBP, and 10-year cumulative SBP) in identical samples. Discrimination of the risk equations fitted with each of these 3 blood pressure variables was compared with observed ASCVD events by computing the C statistic. 8 We also illustrated the predictive ability using calibration plots that compared the expected vs observed risk by deciles of predicted risk. Separately, the predictive ability of the 5-year and 10-year cumulative blood pressure was compared against current SBP using the net reclassification at event rate index and the integrated discrimination index (IDI). Standardized net benefit was plotted against the classification threshold for each blood measure, separately by sex (eFigure in the Supplement). Further 
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Results
This study included 11 767 participants; the mean (SD) index age was 59.1 (4.7) years at risk estimation, 6873 participants (58%) were women, and 1499 (13%) were African American. Those in the highest tertile of 10-year cumulative SBP were older, more likely to be men, and had a higher burden of other CVD risk factors ( Table 1) . In follow-up from risk estimation, 1887 participants (16%) had an ASCVD event.
The ASCVD incidence rate was higher with increasing tertiles of 10-year cumulative SBP from 5.9 events per 1000 person-years in the lowest tertile to 9.9 and 18.4 in the second and third tertiles, respectively. Current SBP and 5-year cumulative SBP were highly correlated (R = 0.86), as were current SBP and 10-year cumulative SBP (R = 0.80). Discrimination was similar for the 3 models across SBP measures for men and women. Likewise, calibration plots visually demonstrated high correlation between predicted and observed events for all 3 blood pressure measures (Figure) . However, the regression coefficients were greater in magnitude for the 5-year and 10-year cumulative SBP compared with single SBP (hazard ratios per multiplicative increase in SBP of 2.69 and 2.74 for 5-and 10-year, respectively, compared with 2.12 for single SBP).
There were significant improvements, although modest, in model performance for both measures of cumulative SBP among both sexes ( Table 2) . For men, the net reclassification index was 0.04 (95% CI, 0.02-0.06) comparing 10-year cumulative SBP and current SBP and 0.03 (95% CI, 0.01-0.05) comparing 5-year cumulative SBP and current SBP. For women, the net reclassification index was 0.03 (95% CI, 0.01-0.06) comparing 10-year cumulative SBP and current SBP and 0.04 (95% CI, 0.02-0.06) comparing 5-year cumulative SBP and current SBP. For men, the absolute IDI was 0.006 (95% CI, 0.004-0.008) comparing 10-year cumulative SBP and current SBP and 0.006 (95% CI, 0.004-0.006) comparing 5-year cumulative SBP and current SBP. For women, the absolute IDI was 0.002 (95% CI, 0.001-0.003) comparing 10-year cumulative SBP and current SBP and 0.002 (95% CI, 0.001-0.003) comparing 5-year cumulative SBP and current SBP. When looking at the relative IDI among men, the 5-year and the 10-year SBP relative IDI was 0.12. Among women, the relative IDI was 0.09 for 5-year cumulative SBP and 0.10 for 10-year cumulative SBP.
Discussion
Despite relatively high correlation between current SBP and long-term cumulative SBP, substituting either 5-or 10-year cumulative SBP in the ASCVD risk prediction equations significantly improved their ability to correctly classify individuals in terms of their risk for ASCVD, although improvements were small in magnitude. These improvements are comparatively modest when considering coronary artery calcium score, another novel cardiovascular risk predictor, 9 but blood pressure is frequently measured and widely available in longitudinal electronic health record data. Implementation of use of cumulative SBP for risk prediction could feasibly occur without change to standard clinical practice, although it might be preferentially implemented in large health systems with robust electronic data capabilities. Other studies have shown the importance of cumulative blood pressure on ASCVD risk 2, 4, 5 ; in a 2015 study, cumulative SBP was a significant predictor of ASCVD events over a 20-year follow-up period, independent of current SBP. 5 Our results extend these findings to test the impact of including cumulative SBP in an ASCVD risk estimator commonly used to support clinical decision making. However, future studies are needed to determine the most appropriate value of cumulative SBP, including time length, whether all measurements in the time period should be given equal weight, and whether functional forms such as trajectories may provide better characterization of cumulative blood pressure than numerical values.
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Limitations This study has several limitations. The generalizability of these findings may be limited to populations similar to the included cohorts. In particular, the sample was predominantly white, and thus findings may not be consistent in other racial/ethnic groups. Further, the sample was limited to those who were CVD-free at the time of risk estimation (mean 
